The HinduHealth
Free risdiplam for patients with SMA in every district
Patients with spinal muscular atrophy will be able to access risdiplam at no cost in every district, according to the announcement. The move would widen access to treatment, though details on timing and delivery were not provided.
This card is an AI-assisted summary of reporting published by The Hindu. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.